Your browser doesn't support javascript.
loading
Patients and families experience with pharmacist care at cystic fibrosis foundation accredited clinics.
Young, David C; Autry, Elizabeth; Zobell, Jeffery T; Kormelink, Lauren; Homa, Karen; Sabadosa, Kathryn A; Kanga, Jamshed; Anstead, Michael; Kuhn, Robert.
Afiliación
  • Young DC; University of Utah Adult Cystic Fibrosis Center, University of Utah College of Pharmacy, Salt Lake City, Utah.
  • Autry E; University of Kentucky HealthCare Pharmacy Services, Lexington, Kentucky.
  • Zobell JT; Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky.
  • Kormelink L; Intermountain Cystic Fibrosis Pediatric Center, Salt Lake City, Utah.
  • Homa K; University of Kentucky HealthCare Pharmacy Services, Lexington, Kentucky.
  • Sabadosa KA; Cystic Fibrosis Foundation, Bethesda, Maryland.
  • Kanga J; The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, New Hampshire.
  • Anstead M; Department of Pediatric Pulmonary Medicine, University of Kentucky College of Medicine, Lexington, Kentucky.
  • Kuhn R; Department of Pediatric Pulmonary Medicine, University of Kentucky College of Medicine, Lexington, Kentucky.
Pediatr Pulmonol ; 54(8): 1216-1224, 2019 08.
Article en En | MEDLINE | ID: mdl-31066229
ABSTRACT
Cystic fibrosis (CF) is a complex genetic, multiorgan disease. The CF Foundation (CFF) recommends a multidisciplinary team (physician, nurse, respiratory therapist, dietitian, physical therapist, social worker, mental health coordinator, clinic coordinator, and pharmacist) to work with patients and families. The objective of our study was to describe the impact of a pharmacist involved in the care of patients and families from their perspective. The CF Patient and Family Experience of Care (PFEC) is a voluntary, 50-question telephonic or internet-based survey designed to continuously collect information from patients and their families regarding their care experience. From August of 2017 through February of 2018, five questions were added to the internet survey to assess the impact of the pharmacist on the care experience. From the 666 respondents, 54% reported that a pharmacist was involved in their CF care. At two CF clinics designated as "full access" to a pharmacist, respondents reported a higher percentage of the CF-team discussed medications compared to those from three clinics designated as "limited access" to the pharmacist (95% vs 67%). Respondents in clinics with "full access" to a pharmacist were significantly more likely to get their medications refilled on time (78% vs 63%) and reported using fewer pharmacies to fill their medications. Pharmacist involvement in CF care may improve patient's access to medication and the ability to sustain use.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Grupo de Atención al Paciente / Farmacéuticos / Fibrosis Quística / Rol Profesional Límite: Female / Humans / Male Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Grupo de Atención al Paciente / Farmacéuticos / Fibrosis Quística / Rol Profesional Límite: Female / Humans / Male Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2019 Tipo del documento: Article